{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:24:53Z","timestamp":1794587093052,"version":"4.9.1"},"reference-count":44,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"National Institute on Drug Abuse of the National Institutes of Health","award":["U01DA051126"],"award-info":[{"award-number":["U01DA051126"]}]},{"name":"National Institute on Drug Abuse of the National Institutes of Health","award":["R01DA057289"],"award-info":[{"award-number":["R01DA057289"]}]},{"name":"National Institute on Drug Abuse of the National Institutes of Health","award":["R01DA060207"],"award-info":[{"award-number":["R01DA060207"]}]},{"name":"National Institute on Drug Abuse of the National Institutes of Health","award":["and T32DA031099"],"award-info":[{"award-number":["and T32DA031099"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychoactive Drugs"],"published-print":{"date-parts":[[2026,10,20]]},"DOI":"10.1080\/02791072.2025.2570937","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:45:00Z","timestamp":1760013900000},"page":"922-931","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["The Epidemiology of Recreational Use and Availability of DOC and DOI in the United States"],"prefix":"10.1080","volume":"58","author":[{"given":"Joseph J.","family":"Palamar","sequence":"first","affiliation":[{"name":"Department of Population Health","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole D.","family":"Fitzgerald","sequence":"additional","affiliation":[{"name":"Columbia University Mailman School of Public Health","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkaa112"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103393"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bku087"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/1941874414528939"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.legalmed.2014.09.001"},{"key":"e_1_3_3_7_1","unstructured":"Center for Behavioral Health Statistics and Quality. 2024. Results from the 2023 National Survey on Drug Use and Health: Detailed tables. Substance Abuse and Mental Health Services Administration. Rockville MD. Accessed March 23 2025. https:\/\/www.samhsa.gov\/data\/report\/2023-nsduh-detailed-tables."},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108286"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1139\/v73-210"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2019.110002"},{"key":"e_1_3_3_11_1","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. 2022. New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU early warning system. Luxembourg: Publications Office of the European Union. Accessed March 23 2025. https:\/\/www.euda.europa.eu\/publications\/rapid-communication\/update-eu-early-warning-system-2022_en."},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2025.112711"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.4c00157"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2024.2412423"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.11.033"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-024-01033-w"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bky051"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11419-022-00628-8"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2608"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2019.109969"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1968.10524531"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2013.863906"},{"key":"e_1_3_3_23_1","unstructured":"National Cancer Institute. 2023. Joinpoint regression program version 5.0. Statistical methodology and applications branch surveillance research program."},{"key":"e_1_3_3_24_1","unstructured":"National Forensic Laboratory Information System. 2025. Public DQS. Accessed July 9 2025."},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/mej.0b013e3282fc765b"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2719"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2020.1761574"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109398"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104417"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2024.112402"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107889"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2690"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104001"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bky039"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1977.10472044"},{"key":"e_1_3_3_36_1","volume-title":"Pihkal: A chemical love story","author":"Shulgin A.","year":"2014","unstructured":"Shulgin, A., and A. Shulgin. 2014. Pihkal: A chemical love story. Berkeley, CA: Transform Press."},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.3667"},{"key":"e_1_3_3_38_1","unstructured":"United National Office on Drugs and Crime. 2020. November 2020 \u2013 UNODC: Commission on Narcotic Drugs decision on international control of AB-FUBINACA 5F-AMB-PINACA 5F-MDMB-PICA 4F-MDMB-BINACA 4-CMC N-ethylhexedrone alpha-PHP flualprazolam etizolam DOC and one precursor enters into force. Accessed March 23 2025. https:\/\/www.unodc.org\/LSS\/Announcement\/Details\/3297afad-f16e-4a4f-89c6-6d3b371ec737."},{"key":"e_1_3_3_39_1","unstructured":"US Drug Enforcement Administration. 2021. 2020 National Drug Threat Assessment DEA-DCT-DIR-008-21. Accessed March 23 2025. https:\/\/www.dea.gov\/sites\/default\/files\/2021-02\/DIR-008-21%202020%20National%20Drug%20Threat%20Assessment_WEB.pdf."},{"key":"e_1_3_3_40_1","unstructured":"US Drug Enforcement Administration. 2023a. Proposed rule: Schedules of controlled substances: Placement of 2 5-dimethoxy-4-iodoamphetamine (DOI) and 2 5-dimethoxy-4-chloroamphetamine (DOC) in schedule I. Accessed March 23 2025. https:\/\/www.federalregister.gov\/documents\/2023\/12\/13\/2023-27289\/schedules-of-controlled-substances-placement-of-25-dimethoxy-4-iodoamphetamine-doi-and#citation-6-p86283."},{"key":"e_1_3_3_41_1","unstructured":"US Drug Enforcement Administration. 2023b. National forensic laboratory information system: NFLIS-Drug 2022 annual report. U.S. Department of Justice Diversion Control Division Springfield VA."},{"key":"e_1_3_3_42_1","unstructured":"US Drug Enforcement Administration. 2025a. Recommended rulings findings of fact conclusions of law and decision of the administrative law judge. Schedules of controlled substances: Placement of 2 5-dimethoxy-4-iodoamphetamine (DOI) and 2 5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I. Docket no. 24\u201324. Accessed June 20 2025."},{"key":"e_1_3_3_43_1","unstructured":"US Drug Enforcement Administration. 2025b. DEA TOX: Quarterly report \u2013 third quarter 2024. Springfield VA. Accessed March 23 2025. https:\/\/www.deadiversion.usdoj.gov\/dea_tox\/quarterly_reports\/3rd-Quarter-2024-DEA-TOX-02132025.pdf."},{"key":"e_1_3_3_44_1","unstructured":"Washington\/Baltimore High Intensity Drug Trafficking Area Program. 2024. 2023 annual report. Accessed March 23 2025. https:\/\/www.hidta.org\/wp-content\/uploads\/2024\/09\/WB-HIDTA-2023-Annual-Report-Web.pdf."},{"key":"e_1_3_3_45_1","unstructured":"World Health Organization. 2019. Critical review report: DOC (4-chloro-2 5-dimethoxyamfetamine). Expert committee on drug dependence. Forty-second meeting. Geneva 21\u201325 October 2019. Accessed March 23 2025. https:\/\/researchonline.ljmu.ac.uk\/id\/eprint\/11444\/1\/ECDD42_DOC.pdf."}],"container-title":["Journal of Psychoactive Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/02791072.2025.2570937","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/02791072.2025.2570937","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/02791072.2025.2570937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:38:59Z","timestamp":1794584339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/02791072.2025.2570937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10,20]]}},"alternative-id":["10.1080\/02791072.2025.2570937"],"URL":"https:\/\/doi.org\/10.1080\/02791072.2025.2570937","relation":{},"ISSN":["0279-1072","2159-9777"],"issn-type":[{"value":"0279-1072","type":"print"},{"value":"2159-9777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ujpd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ujpd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-04-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}